Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results Expected in ...
Genetic testing for cancer should be the norm now, experts say. Here’s when to request it.
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
The Street Journal54m
Scientists find promising pancreatic cancer leads
As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most difficult cancer to survive. The survival rate five years after diagnosis is 6-14%, but ...